Heart and lung diseases Archives - InnoHEALTH magazine

A booster shot for innovations in India

InnoHEALTH Magazine — Wed, 28 Feb 2018 06:49:39 +0000

InnoHEALTH in Bengaluru October 2017

Handholding Innovative companies from EU for Indian Market Access: A day well spent in Bengaluru. Sachin Gaur spells out the details of the magical meeting between the two sides opening doors for a brighter and fruitful future.

InnovatioCuris, IC in partnership with NovoJuris and with support of Honorary Consul of Estonia in Bengaluru, Karnataka Drugs and Pharmaceuticals Manufacturers’ Association, (KDPMA) organized the Bengaluru leg of InnoHEALTH conference followed by B2B meetings.

When in the planning stages of the delegation visit we were strongly advised by the Department of Biotechnology, Government of India to include Bengaluru in our itinerary. As you know Bengaluru is probably the center of all the action in the country when it comes to biotech industry.

So, we looked at a stakeholder approach considering that many of the companies/delegates were to visit India for the first time. We realized that the main stakeholders for such a visit would be experts on Indian health sector, distribution channel experts, investors and legal experts.

[vc_single_image image=”3416″ img_size=”500×300″ alignment=”center” onclick=”link_image”]

[vc_single_image image=”3417″ img_size=”500×300″ alignment=”center” onclick=”link_image”]

Since, Estonia was our country partner we reached out to the Honorary Consul in Bengaluru who further connected us with KDPMA and other industry bodies. We, also, partnered with NovoJuris given their expertise in legal matters and strong interest in the health sector. The whole program was put together in partnership with a strong collaboration of the IC and the NovoJuris team.

The Bengaluru visit was planned for 21st of September 2017 with the first half of sessions with experts in the areas identified. The session about Indian health sector was delivered by Dr. V C Shanmugandan from Association of Private Hospitals of India and Ms. Swetha Suresh from Swissnex. The legal session was delivered by various experts of the NovoJuris team. The investor session saw experts from Accel Partners and PWC. The distribution session was run by officials of KDPMA, Mr. Sunil Attavar and Mr. Harish Jain.

Post lunch and evening sessions were reserved for the B2B meeting followed by cocktails, where various business leaders interested in partnering with the EU companies engaged the delegates. The EU delegation was very happy with the quality of the conference and the contacts made during the B2B sessions. It was a good learning experience for us as well to bring the stakeholders together and we gear up to do it again in 2018!

[vc_cta h2=”Dr. V. K. Sharma”]

“To share some positive facts about the Indian Pharma Industry: We are the most economical medicine manufacturer in the world; India is the third largest producer in volume and 10th largest in business globally; Thirty percent of US requirements are catered by Indian pharma manufacturers; We export to almost 200 countries in the world; One out of the three pills consumed in the world is from India. And all this has been achieved in the last 30 years when Indian government came out with Pharma policy in 1986.”

[/vc_cta]

[vc_cta h2=”Dr. Vinod Nikhra”]

“India has been on the forefront of providing some of the leading medical facilities that are uniquely innovative and ingenious. Indian pharma industry has gone beyond molecular contributions and is in fact manufacturing some ground breaking gadgets and machines that contribute to curing people from extreme ailments like the heart and lung diseases, transplants and coronary diseases. Of course pricing is an issue that is faced by the industry and the irony is that despite the price being much cheaper than the international market, it still remains out of the reach.”

[/vc_cta]

Want to write for InnoHEALTH? send us your article at magazine@innovatiocuris.com

Read all the issues of InnoHEALTH magazine:
InnoHEALTH Volume 1 Issue 1 (July to September 2016) – https://goo.gl/iWAwN2
InnoHEALTH Volume 1 Issue 2 (October to December 2016) – https://goo.gl/4GGMJz
InnoHEALTH Volume 2 Issue 1 (January to March 2017) – https://goo.gl/DEyKnw
InnoHEALTH Volume 2 Issue 2 (April to June 2017) – https://goo.gl/Nv3eev
InnoHEALTH Volume 2 Issue 3 (July to September 2017) – https://goo.gl/MCVjd6
InnoHEALTH Volume 2 Issue 4 (October to December 2017) – http://amzn.to/2B2UMLw
InnoHEALTH Volume 3 Issue 1 (January to March 2018) – https://goo.gl/fksdQx

Connect with InnovatioCuris on:
Facebook: https://www.facebook.com/innovatiocuris
Twitter: https://twitter.com/innovatiocuris
LinkedIn: https://www.linkedin.com/groups/7043791
Stay updated about IC, visit: www.innovatiocuris.com

The post A booster shot for innovations in India appeared first on InnoHEALTH magazine.

Understanding the chemistry of good health

InnoHEALTH Magazine — Thu, 22 Feb 2018 05:01:12 +0000

Today’s pharma industry has gone beyond molecular structures and rolling out tablets. Since the first Pharma Policy by the Indian government in 1986, the industry has come a long way and today every third pill consumed in the world is from India.

Keynote Address: Dr. Ronald Heslegrave
Moderator: Dr. Shiban Ganju
Panelists:
• Dr. V.K, Sharma
• Dr. Vinod Nikhra
• Dr. Anjana Batni
• Ashish Kumar

It all started with a chemical reaction and hence it’s very obvious that it can only be controlled with a series of chemical reactions. And, so came the pharma industry more than 200 years ago.

That’s history, today the pharma industry, especially in India is very modern in its approach and is shouldering the health sector with its innovative approach and modern innovations. But growing back to the future, India is also taking lead to promote its age-old Ayurveda that is as effective as any other modern science.Opening the floor to this high voltage discussion, Dr. Shiban Ganju Atrimed Pharmaceuticals in the US said, “Until now human body has been an amalgamation of cells, tissues and organs. Now, the human body has emerged as a conglomeration of biochemical process that are scattered around and work in close coordination with each other with the sole purpose of keeping the human body alive.

[vc_single_image image=”3373″ img_size=”500×300″ alignment=”center” onclick=”link_image”]

[vc_single_image image=”3374″ img_size=”500×300″ alignment=”center” onclick=”link_image”]

“Another baffling reality for me is that Ayurveda introduces us to the benefits of plants and their properties. After all, trees and plants appeared much before the pharma industry. Plants have been in existence for more than two billion years and our pharma industry is less than 200 years old. Not only that, plants have a self-preserving system and can fight any bacterial attack or any foreign infection; that makes them the most natural source for our pharma industry – even in these modern times. More so in the modern times!” he concluded his thoughts with his faith in age-old Ayurveda.

Closer to the ground, Dr. V.K. Sharma shared some startling facts about the Indian pharma sector: “We are the most economical medicine manufacturer in the world. India is the third largest producer in volume and 10th largest in business globally. Thirty percent of US requirements are catered by Indian pharma manufacturers. We export to almost 200 countries in the world. One out of every three pills consumed in the world is from India. And all this has been achieved in the last 30 years when the Indian government came out with its Pharma policy in 1986.”

“Despite that India pharma industry has been facing many challenges and to address those issues now there’s a new Drug & Pharma policy that will encourage more research and development in the country making the pharma industry more robust and bigger than ever.”

Dr. Vinod Nikhra highlighted the contribution of Indian pharma industry beyond the “pill factor” as he emphasized the broad developments in the sector and what makes it click internationally.

On the flip side, he added, “Of course pricing is an issue that is faced by the industry and the irony is that despite the price being much cheaper than the international market, it still remains out of reach of most Indians. For this we are counting on government to extend some encouraging and bold steps to make medical facilities and good health within the reach of all.”

Highlighting the problems of the Indian Pharma industry, Ashish Kumar from Medicea Technology Solutions said that, “The problem that we are trying to solve is two-fold. First one is facing the encroachment of fake and counterfeit drugs which is growing at 25% CAGR per year and is valued at $10 billion annually. We are working closely with IBM to address this problem and are on the brink of perfecting a fool-proof system that will block every fake or counterfeit drug in the country.”

[vc_single_image image=”3375″ img_size=”500×300″ alignment=”center” onclick=”link_image”]

“Second project that we are working on is to track and design demographics of drug consumption. Use of a particular drug in a zone or a larger region can give a very useful insight to health authorities as to what is the cause of those ailments that are leading to high consumption of particular drugs in that particular area.”

Dr. Anjana Batni, an Ayurveda researcher from Atrimed Biotech brought glory to Indian past highlighting the relevance and importance of age-old Ayurveda that is getting increasingly accepted universally and is completing the modern medicine and not competing with it.

Highlighting the contributions of her organization, she said, “With the intention to modernize Ayurveda, we are collating data about the plants and their use. Ayurveda texts identify how to diagnose, manage and how to cure diseases; and they also have vast information on plant molecules and so far, less than 10 percent of these plant molecules identified in Ayurveda texts are in practice. Our efforts are to classify all the plant molecules and store them digitally for use by Ayurveda practitioners and other medical platforms. As of now we have a library of 2.8 lakh plant molecules identified and digitally stored at our facility.”

“We are soon embarking on clinical trials of our discoveries and we hope that our efforts can bridge the gap between modern pharma and Ayurveda with our discoveries,” concluded Dr Batni to a welcome applause from the audience.

[vc_cta h2=”Maj Gen Jagtar Singh”]

“Outbreaks are a huge threat in the army as we have a large body of human beings living together. For this we have a large army of efficient doctors and medical staff to contain such outbreaks. The second challenge is harsh ground realities as our soldiers work in extreme conditions. To treat them at these extreme conditions, the Indian army has done some specific researches that have been accepted all over the world and not just with our soldiers.”

[/vc_cta]

[vc_cta h2=”Dr Rishikesha T. Krishnan”]

“Innovations in health care must consider three aspects: Begin with identifying core functionalities of equipment without having to sacrifice on the safety aspect. Secondly, start from scratch. Build upwards and incorporate all the technical features that you feel are essential to the product; downscaling features will not necessarily downscale your cost; lastly, collaborate and team up with other who will complement your product, effort and your intentions. There’s no one entity that has all the knowledge and resources to develop any product in entirety.”

[/vc_cta]

[vc_cta h2=”Dr S. Venkataramanaiah”]

“Data clearly indicates that there’s a huge demand for private players in the health sector. Everyone is and needs to be medically insured and ensured of good health by private or a government body. On the other hand, health care has some major deficiencies like availability of medical help at anytime and anywhere. Like you have road-side assistance available all over the country, such a facility for health and medical urgencies is still not available.”

[/vc_cta]

Want to write for InnoHEALTH? send us your article at magazine@innovatiocuris.com

The post Understanding the chemistry of good health appeared first on InnoHEALTH magazine.